Laura Suhlrie , Raga Ayyagari , Camille Mba , Kjell Olsson , Harold Torres-Aparcana , Steven James , Elpida Vounzoulaki , Daniel B. Ibsen
{"title":"远程医疗预防2型糖尿病的有效性:干预措施的系统回顾和荟萃分析","authors":"Laura Suhlrie , Raga Ayyagari , Camille Mba , Kjell Olsson , Harold Torres-Aparcana , Steven James , Elpida Vounzoulaki , Daniel B. Ibsen","doi":"10.1016/j.dsx.2025.103252","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>To evaluate the effectiveness of telemedicine-delivered diet and/or exercise interventions to prevent type 2 diabetes (T2D) in people at risk.</div></div><div><h3>Methods</h3><div>Embase (via Ovid), Medline (via Ovid), Web of Science, CINAHL, Scopus and SciELO were searched from January 2010–December 2020 for intervention studies using a diet and/or exercise intervention delivered through telemedicine for T2D prevention in people at risk. Parallel randomised controlled trials were meta-analysed, and other intervention designs narratively synthesized.</div></div><div><h3>Results</h3><div>We identified 11,645 studies via database searches, of which 226 were full-text screened, and 52 interventions included; 32 were included in the meta-analysis and 20 in the narrative synthesis. Telemedicine interventions reduced body weight (mean difference (MD): −1.66 kg, 95 % confidence interval (CI) −2.48,-0.90, I<sup>2</sup> = 81 %, n<sub>studies</sub> = 17), body mass index (MD -0.71 kg/m<sup>2</sup>, 95 % CI -1.06,-0.37, I<sup>2</sup> = 70 %, n<sub>studies</sub> = 11), waist circumference (MD -2.82 cm, 95 % CI -5.16,-2.35, I<sup>2</sup> = 84 %, n<sub>studies</sub> = 8) and HbA1c (MD -0.07 %, 95 % CI -0.14,0.00, I<sup>2</sup> = 71 %, n<sub>studies</sub> = 11). No significant effects were found for other clinical outcomes. The narrative synthesis supported the results. The longest follow-up time was up to 24 months.</div></div><div><h3>Conclusions</h3><div>Our study demonstrates effectiveness for telemedicine-delivered interventions in preventing T2D in people at risk, specifically in people with overweight/obesity.</div></div>","PeriodicalId":48252,"journal":{"name":"Diabetes & Metabolic Syndrome-Clinical Research & Reviews","volume":"19 5","pages":"Article 103252"},"PeriodicalIF":3.4000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The effectiveness of telemedicine in the prevention of type 2 diabetes mellitus: a systematic review and meta-analysis of interventions\",\"authors\":\"Laura Suhlrie , Raga Ayyagari , Camille Mba , Kjell Olsson , Harold Torres-Aparcana , Steven James , Elpida Vounzoulaki , Daniel B. Ibsen\",\"doi\":\"10.1016/j.dsx.2025.103252\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective</h3><div>To evaluate the effectiveness of telemedicine-delivered diet and/or exercise interventions to prevent type 2 diabetes (T2D) in people at risk.</div></div><div><h3>Methods</h3><div>Embase (via Ovid), Medline (via Ovid), Web of Science, CINAHL, Scopus and SciELO were searched from January 2010–December 2020 for intervention studies using a diet and/or exercise intervention delivered through telemedicine for T2D prevention in people at risk. Parallel randomised controlled trials were meta-analysed, and other intervention designs narratively synthesized.</div></div><div><h3>Results</h3><div>We identified 11,645 studies via database searches, of which 226 were full-text screened, and 52 interventions included; 32 were included in the meta-analysis and 20 in the narrative synthesis. Telemedicine interventions reduced body weight (mean difference (MD): −1.66 kg, 95 % confidence interval (CI) −2.48,-0.90, I<sup>2</sup> = 81 %, n<sub>studies</sub> = 17), body mass index (MD -0.71 kg/m<sup>2</sup>, 95 % CI -1.06,-0.37, I<sup>2</sup> = 70 %, n<sub>studies</sub> = 11), waist circumference (MD -2.82 cm, 95 % CI -5.16,-2.35, I<sup>2</sup> = 84 %, n<sub>studies</sub> = 8) and HbA1c (MD -0.07 %, 95 % CI -0.14,0.00, I<sup>2</sup> = 71 %, n<sub>studies</sub> = 11). No significant effects were found for other clinical outcomes. The narrative synthesis supported the results. The longest follow-up time was up to 24 months.</div></div><div><h3>Conclusions</h3><div>Our study demonstrates effectiveness for telemedicine-delivered interventions in preventing T2D in people at risk, specifically in people with overweight/obesity.</div></div>\",\"PeriodicalId\":48252,\"journal\":{\"name\":\"Diabetes & Metabolic Syndrome-Clinical Research & Reviews\",\"volume\":\"19 5\",\"pages\":\"Article 103252\"},\"PeriodicalIF\":3.4000,\"publicationDate\":\"2025-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Diabetes & Metabolic Syndrome-Clinical Research & Reviews\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1871402125000694\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes & Metabolic Syndrome-Clinical Research & Reviews","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1871402125000694","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
摘要
目的评价远程医疗饮食和/或运动干预对高危人群预防2型糖尿病(T2D)的有效性。方法检索sembase(通过Ovid)、Medline(通过Ovid)、Web of Science、CINAHL、Scopus和SciELO,检索2010年1月至2020年12月通过远程医疗提供的饮食和/或运动干预对高危人群预防T2D的干预研究。对平行随机对照试验进行meta分析,并对其他干预设计进行叙述性综合。结果:我们通过数据库检索确定了11,645项研究,其中226项是全文筛选,包括52项干预措施;32例纳入元分析,20例纳入叙事综合。远程医疗干预降低了体重(平均差值(MD): - 1.66 kg, 95%可信区间(CI): - 2.48,-0.90, I2 = 81%, nstudies = 17),体重指数(MD -0.71 kg/m2, 95% CI -1.06,-0.37, I2 = 70%, nstudies = 11),腰围(MD -2.82 cm, 95% CI -5.16,-2.35, I2 = 84%, nstudies = 8)和糖化血红蛋白(MD - 0.07%, 95% CI -0.14,0.00, I2 = 71%, nstudies = 11)。其他临床结果未发现显著影响。叙事综合支持了结果。最长随访时间达24个月。我们的研究证明了远程医疗干预在高危人群,特别是超重/肥胖人群中预防T2D的有效性。
The effectiveness of telemedicine in the prevention of type 2 diabetes mellitus: a systematic review and meta-analysis of interventions
Objective
To evaluate the effectiveness of telemedicine-delivered diet and/or exercise interventions to prevent type 2 diabetes (T2D) in people at risk.
Methods
Embase (via Ovid), Medline (via Ovid), Web of Science, CINAHL, Scopus and SciELO were searched from January 2010–December 2020 for intervention studies using a diet and/or exercise intervention delivered through telemedicine for T2D prevention in people at risk. Parallel randomised controlled trials were meta-analysed, and other intervention designs narratively synthesized.
Results
We identified 11,645 studies via database searches, of which 226 were full-text screened, and 52 interventions included; 32 were included in the meta-analysis and 20 in the narrative synthesis. Telemedicine interventions reduced body weight (mean difference (MD): −1.66 kg, 95 % confidence interval (CI) −2.48,-0.90, I2 = 81 %, nstudies = 17), body mass index (MD -0.71 kg/m2, 95 % CI -1.06,-0.37, I2 = 70 %, nstudies = 11), waist circumference (MD -2.82 cm, 95 % CI -5.16,-2.35, I2 = 84 %, nstudies = 8) and HbA1c (MD -0.07 %, 95 % CI -0.14,0.00, I2 = 71 %, nstudies = 11). No significant effects were found for other clinical outcomes. The narrative synthesis supported the results. The longest follow-up time was up to 24 months.
Conclusions
Our study demonstrates effectiveness for telemedicine-delivered interventions in preventing T2D in people at risk, specifically in people with overweight/obesity.
期刊介绍:
Diabetes and Metabolic Syndrome: Clinical Research and Reviews is the official journal of DiabetesIndia. It aims to provide a global platform for healthcare professionals, diabetes educators, and other stakeholders to submit their research on diabetes care.
Types of Publications:
Diabetes and Metabolic Syndrome: Clinical Research and Reviews publishes peer-reviewed original articles, reviews, short communications, case reports, letters to the Editor, and expert comments. Reviews and mini-reviews are particularly welcomed for areas within endocrinology undergoing rapid changes.